Plasma and synovial fluid leptin levels are observed to be elevated in patients with erosive and non-erosive RA and treatment with disease-modifying anti-rheumatic drugs (DMARDS) subsequently decreases serum leptin levels [7]. The gene discussed is LEP; the disease is rheumatoid arthritis.